Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome

Texas Heart Institute Journal

Volumn 36, Issue 2, 2009, Pages 134-139

  Li, Ximing ^a   Cong, Hongliang ^a  

^a TIANJIN CHEST HOSPITAL   (China)

Author keywords

Binding sites, antibody; Biological markers blood; Blood platelets chemistry pathology physiology ultrastructure; Cardiovascular diseases blood; Cell communication analysis physiology; Cell membrane metabolism physiology; Platelet activation adhesiveness physiology; Platelet glycoprotein GPIIb IIIa complex analysis biosynthesis metabolism physiology; Platelet membrane glycoproteins analysis; Receptors, cell surface physiology; Signal transduction physiology

Indexed keywords

BETA2 INTEGRIN; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE SYK;

ACUTE CORONARY SYNDROME; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; NONHUMAN; PLATELET MICROPARTICLE; PROTEIN BINDING; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

ACUTE CORONARY SYNDROME; ANIMALS; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES; MUSCLE, SMOOTH, VASCULAR; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 65949085349     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006;48(2):180-186 (Pubitemid 44309805)
2. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967;13(3):269-288
3. Sandberg H, Bode AP, Dombrose FA, Hoechli M, Lentz BR. Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and platelet factor 3. Thromb Res 1985;39(1):63-79. (Pubitemid 15008441)
4. George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986;78(2):340-348
5. Gawaz M, Ott I, Reininger AJ, Heinzmann U, Neumann FJ. Agglutination of isolated platelet membranes. Arterioscler Thromb Vasc Biol 1996;16(5):621-627 (Pubitemid 26153105)
6. Barry OP, FitzGerald GA. Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 1999;82(2):794-800.
7. Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998;102(1):136-144 (Pubitemid 28323840)
8. Bode AP, Orton SM, Frye MJ, Udis BJ. Vesiculation of platelets during in vitro aging. Blood 1991;77(4):887-895
9. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988;71(4):831-843
10. van der Zee PM, Biro E, Ko Y, de Winter RJ, Hack CE, Sturk A, Nieuwland R. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 2006;52(4):657-664
11. Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991;266(26):17261-17268 (Pubitemid 21907934)
12. Gemmell CH, Sefton MV, Yeo EL. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. J Biol Chem 1993;268(20):14586-14589
13. Siess W. Molecular mechanisms of platelet activation. Physiol Rev 1989;69(1):58-178. (Pubitemid 19040137)
14. Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002;46(6):1498-1503 (Pubitemid 34620195)
15. Thiagarajan P, Tait JF. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem 1991;266(36):24302-24307 (Pubitemid 21908941)
16. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990;75(1):128-138 (Pubitemid 20031500)
17. Wencel-Drake JD, Dieter MG, Lam SC. Immunolocalization of beta 1 integrins in platelets and platelet-derived microvesicles. Blood 1993;82(4):1197-1203 (Pubitemid 23253994)
18. de Bruijne-Admiraal LG, Modderman PW, Von dem Borne AE, Sonnenberg A. P-selectin mediates Ca(2+)-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood 1992;80(1):134-142
19. Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, et al. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989;59(2):305-312
20. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 1993;74(3):541-554 (Pubitemid 23244619)
21. Siljander P, Carpen O, Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood 1996;87(11):4651-4663 (Pubitemid 26162364)
22. Haluska CK, Riske KA, Marchi-Artzner V, Lehn JM, Lipowsky R, Dimova R. Time scales of membrane fusion revealed by direct imaging of vesicle fusion with high temporal resolution. Proc Natl Acad Sci USA 2006;103(43):15841-15846 (Pubitemid 44657554)
23. Gruber R, Varga F, Fischer MB, Watzek G. Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res 2002;13(5):529-535 (Pubitemid 41713080)
24. Owens MR, Holme S, Cardinali S. Platelet microvesicles adhere to subendothelium and promote adhesion of platelets. Thromb Res 1992;66(2-3):247-258
25. Chirinos JA, Velazquez H, Canoniero M, Soriano AO, Bernal- Mizrachi L, Jy W, et al. Levels of GP-IIb/IIIa positive platelet microparticles (PMP) but not CD31+/CD42+ PMP predict adverse outcomes in troponin-negative patients with chest pain. Blood 2004;104(11 Pt 1):2583.
26. Boukerche H, Berthier-Vergnes O, Bailly M, Dore JF, Leung LL, McGregor JL. A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo. Blood 1989;74(3):909-912 (Pubitemid 19210002)
27. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987;238(4826):491-497
28. Salanova B, Choi M, Rolle S, Wellner M, Luft FC, Kettritz R. Beta2-integrins and acquired glycoprotein IIb/IIIa (GPIIb/ IIIa) receptors cooperate in NF-kappaB activation of human neutrophils. J Biol Chem 2007;282(38):27960-27969 (Pubitemid 47529545)
29. Fidler IJ, Raz A, Fogler WE, Kirsh R, Bugelski P, Poste G. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res 1980;40(12):4460-4466 (Pubitemid 11199705)
30. Schroit AJ, Fidler IJ. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res 1982;42(1):161-167 (Pubitemid 12207265)
31. Mehta K, Lopez-Berestein G, Hersh EM, Juliano RL. Uptake of liposomes and liposome-encapsulated muramyl dipeptide by human peripheral blood monocytes. J Reticuloendothel Soc 1982;32(2):155-164 (Pubitemid 12034302)
32. Ratner S, Schroit AJ, Vinson SB, Fidler IJ. Analogous recognition of phospholipids by insect phagocytes and mammalian macrophages. Proc Soc Exp Biol Med 1986;182(2):272-276 (Pubitemid 16087259)
33. Allen TM, Williamson P, Schlegel RA. Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. Proc Natl Acad Sci USA 1988;85(21):8067-8071 (Pubitemid 18272075)
34. Mietto L, Boarato E, Toffano G, Bruni A. Internalization of phosphatidylserine by adherent and non-adherent rat mononuclear cells. Biochim Biophys Acta 1989;1013(1):1-6. (Pubitemid 19219148)
35. Tanaka Y, Schroit AJ. Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells. Recognition by autologous macrophages. J Biol Chem 1983;258(18):11335-11343
36. Hebbel RP, Miller WJ. Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia. Blood 1984;64(3):733-741 (Pubitemid 14073496)
37. Schwartz RS, Tanaka Y, Fidler IJ, Chiu DT, Lubin B, Schroit AJ. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J Clin Invest 1985;75(6):1965-1972. (Pubitemid 15233585)
38. Connor J, Pak CC, Schroit AJ. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 1994;269(4):2399-2404
39. Pradhan D, Williamson P, Schlegel RA. Phosphatidylserine vesicles inhibit phagocytosis of erythrocytes with a symmetric transbilayer distribution of phospholipids. Mol Membr Biol 1994;11(3):181-187
40. Sambrano GR, Parthasarathy S, Steinberg D. Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. Proc Natl Acad Sci USA 1994;91(8):3265-3269 (Pubitemid 24130217)
41. Sambrano GR, Steinberg D. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci USA 1995;92(5):1396-1400
42. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148(7):2207-2216
43. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992;149(12):4029-4035 (Pubitemid 23068888)
44. Schlegel RA, Stevens M, Lumley-Sapanski K, Williamson P. Altered lipid packing identifies apoptotic thymocytes. Immunol Lett 1993;36(3):283-288 (Pubitemid 23214535)
45. Mower DA Jr, Peckham DW, Illera VA, Fishbaugh JK, Stunz LL, Ashman RF. Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. J Immunol 1994;152(10):4832-4842 (Pubitemid 24139076)
46. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84(5):1415-1420 (Pubitemid 24273007)
47. Bennett MR, Gibson DF, Schwartz SM, Tait JF. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res 1995;77(6):1136-1142
48. Homburg CH, de Haas M, von dem Borne AE, Verhoeven AJ, Reutelingsperger CP, Roos D. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 1995;85(2):532-540
49. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995;182(5):1545-1556
50. Shiratsuchi A, Umeda M, Ohba Y, Nakanishi Y. Recognition of phosphatidylserine on the surface of apoptotic spermatogenic cells and subsequent phagocytosis by Sertoli cells of the rat. J Biol Chem 1997;272(4):2354-2358 (Pubitemid 27058522)
51. Pradhan D, Krahling S, Williamson P, Schlegel RA. Multiple systems for recognition of apoptotic lymphocytes by macrophages. Mol Biol Cell 1997;8(5):767-778 (Pubitemid 27255021)
52. Fadok VA, Xue D, Henson P. If phosphatidylserine is the death knell, a new phosphatidylserine-specific receptor is the bellringer. Cell Death Differ 2001;8(6):582-587 (Pubitemid 32586594)
53. Janowska-Wieczorek A, Majka M, Kijowski J, Baj-Krzyworzeka M, Reca R, Turner AR, et al. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 2001;98(10):3143-3149
54. Jy W, Mao WW, Horstman L, Tao J, Ahn YS. Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 1995;21(3):217-231 (Pubitemid 26083518)
55. Merten M, Pakala R, Thiagarajan P, Benedict CR. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999;99(19):2577-2582 (Pubitemid 29228290)
56. Forlow SB, McEver RP, Nollert MU. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000;95(4):1317-1323 (Pubitemid 30099841)
57. Kim HK, Song KS, Chung JH, Lee KR, Lee SN. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004;124(3):376-384 (Pubitemid 38167990)
58. Barry OP, Pratico D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997;99(9):2118-2127 (Pubitemid 27203768)
59. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 2005;288(3):H1004-9. (Pubitemid 40269999)
60. Nomura S, Suzuki M, Kido H, Yamaguchi K, Fukuroi T, Yanabu M, et al. Differences between platelet and microparticle glycoprotein IIb/IIIa. Cytometry 1992;13(6):621-629
61. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001;104(22):2649-2652 (Pubitemid 33108128)
62. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003;59(2):277-287 (Pubitemid 37272022)
63. Shattil SJ, Brass LF. Induction of the fibrinogen receptor on human platelets by intracellular mediators. J Biol Chem 1987;262(3):992-1000. (Pubitemid 17028403)
64. Brader S, Eccles SA. Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumori 2004;90(1):2-8. (Pubitemid 38541717)
65. Qi JH, Matsumoto T, Huang K, Olausson K, Christofferson R, Claesson-Welsh L. Phosphoinositide 3 kinase is critical for survival, mitogenesis and migration but not for differentiation of endothelial cells. Angiogenesis 1999;3(4):371-380 (Pubitemid 129643980)